Literature DB >> 30416854

BRMS1 coordinates with LSD1 and suppresses breast cancer cell metastasis.

Rongfang Qiu1, Hang Shi1, Shuang Wang1, Shuai Leng1, Ruiqiong Liu1, Yu Zheng1, Wei Huang1, Yi Zeng1, Jie Gao1, Kai Zhang1, Yongqiang Hou1, Dandan Feng1, Yang Yang1.   

Abstract

Breast carcinoma metastasis suppressor gene 1 (BRMS1) encodes an inhibitor of metastasis and is reported in many types of tumor metastasis. However, the mechanism of BRMS1-mediated inhibition of breast cancer metastasis at the transcriptional level remains elusive. Here, we identified using affinity purification and mass spectrometry (MS) that BRMS1 is an integral component of the LSD1/CoREST corepressor complex. Analysis of the BRMS1/LSD1 complex using high-throughput RNA deep sequencing (RNA-seq) identified a cohort of target genes such as VIM, INSIG2, KLK11, MRPL33, COL5A2, OLFML3 and SLC1A1, some of which are metastasis-related. Our results have showed that BRMS1 together with LSD1 are required for inhibition of breast cancer cell migration and invasion. Collectively, these findings demonstrate that BRMS1 executes transcriptional suppression of breast cancer metastasis by associating with the LSD1 and thus can be targeted for breast cancer therapy.

Entities:  

Keywords:  BRMS1; LSD1; Vimentin; breast cancer; metastasis

Year:  2018        PMID: 30416854      PMCID: PMC6220148     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  54 in total

1.  SIP, a novel ankyrin repeat containing protein, sequesters steroid receptor coactivators in the cytoplasm.

Authors:  Ying Zhang; Hua Zhang; Jing Liang; Wenhua Yu; Yongfeng Shang
Journal:  EMBO J       Date:  2007-05-03       Impact factor: 11.598

2.  Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer.

Authors:  Brandon J Metge; Andra R Frost; Judy A King; Donna Lynn Dyess; Danny R Welch; Rajeev S Samant; Lalita A Shevde
Journal:  Clin Exp Metastasis       Date:  2008-06-20       Impact factor: 5.150

3.  Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells.

Authors:  Preeti Kapoor; Marnie M Saunders; Zhongyong Li; Zhiyi Zhou; Nate Sheaffer; Elaine L Kunze; Rajeev S Samant; Danny R Welch; Henry J Donahue
Journal:  Int J Cancer       Date:  2004-09-20       Impact factor: 7.396

4.  BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process.

Authors:  Pushkar A Phadke; Kedar S Vaidya; Kevin T Nash; Douglas R Hurst; Danny R Welch
Journal:  Am J Pathol       Date:  2008-02-14       Impact factor: 4.307

5.  Effect of BRMS1 on tumorigenicity and metastasis of human rectal cancer.

Authors:  Yi Zhang; Jie Guan; Yanlai Sun; Jie Chai; Tao Zou; Weipeng Gong; Zhenyu Zhu; Xin Liu; Qingsheng Hou; Xilin Song
Journal:  Cell Biochem Biophys       Date:  2014-09       Impact factor: 2.194

6.  Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells.

Authors:  Douglas R Hurst; Yi Xie; Kedar S Vaidya; Alka Mehta; Blake P Moore; Mary Ann Accavitti-Loper; Rajeev S Samant; Ritu Saxena; Alexandra C Silveira; Danny R Welch
Journal:  J Biol Chem       Date:  2008-01-22       Impact factor: 5.157

7.  Insulin-induced gene 2 expression correlates with colorectal cancer metastasis and disease outcome.

Authors:  Shengjie Sun; Guoqing Zhang; Qiong Sun; Zhiyong Wu; Weiwei Shi; Bo Yang; Ying Li
Journal:  IUBMB Life       Date:  2015-12-10       Impact factor: 3.885

Review 8.  Breast cancer as a systemic disease: a view of metastasis.

Authors:  A J Redig; S S McAllister
Journal:  J Intern Med       Date:  2013-08       Impact factor: 8.989

9.  Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription.

Authors:  William J Meehan; Rajeev S Samant; James E Hopper; Michael J Carrozza; Lalita A Shevde; Jerry L Workman; Kristin A Eckert; Michael F Verderame; Danny R Welch
Journal:  J Biol Chem       Date:  2003-10-26       Impact factor: 5.157

10.  Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis.

Authors:  Yuan Liu; Philip W Smith; David R Jones
Journal:  Mol Cell Biol       Date:  2006-09-25       Impact factor: 4.272

View more
  11 in total

Review 1.  Regulation of breast cancer metastasis signaling by miRNAs.

Authors:  Belinda J Petri; Carolyn M Klinge
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

2.  Transcriptomic Analysis of Breast Cancer Patients Sensitive and Resistant to Chemotherapy: Looking for Overall Survival and Drug Resistance Biomarkers.

Authors:  Carlos A Barrón-Gallardo; Mariel Garcia-Chagollán; Andres J Morán-Mendoza; Raul Delgadillo-Cristerna; María G Martínez-Silva; Adriana Aguilar-Lemarroy; Luis F Jave-Suárez
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

3.  Environmental cues from neural crest derivatives act as metastatic triggers in an embryonic neuroblastoma model.

Authors:  Dounia Ben Amar; Karine Thoinet; Benjamin Villalard; Olivier Imbaud; Clélia Costechareyre; Loraine Jarrosson; Florie Reynaud; Julia Novion Ducassou; Yohann Couté; Jean-François Brunet; Valérie Combaret; Nadège Corradini; Céline Delloye-Bourgeois; Valérie Castellani
Journal:  Nat Commun       Date:  2022-05-10       Impact factor: 17.694

Review 4.  BRMS1: a multifunctional signaling molecule in metastasis.

Authors:  Rosalyn C Zimmermann; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

5.  Olfactomedin-like 3: possible functions in embryonic development and tumorigenesis.

Authors:  Ying Jin; Ji-Liang Li
Journal:  Chin Med J (Engl)       Date:  2019-07-20       Impact factor: 2.628

Review 6.  Abnormal Expression of Mitochondrial Ribosomal Proteins and Their Encoding Genes with Cell Apoptosis and Diseases.

Authors:  Guomin Huang; Hongyan Li; Hong Zhang
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

7.  Microglia-Derived Olfactomedin-like 3 Promotes Pro-Tumorigenic Microglial Function and Malignant Features of Glioma Cells.

Authors:  Ryan G Toedebusch; Christopher A Lucchesi; Eshetu T Debebe; Luke A Wittenburg; Xinbin Chen; Christine M Toedebusch
Journal:  Int J Mol Sci       Date:  2021-12-02       Impact factor: 6.208

8.  Alpha Mangostin and Cisplatin as Modulators of Exosomal Interaction of Ovarian Cancer Cell with Fibroblasts.

Authors:  Paulina Borzdziłowska; Ilona Bednarek
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

Review 9.  A state-of-the-art review on LSD1 and its inhibitors in breast cancer: Molecular mechanisms and therapeutic significance.

Authors:  Guan-Jun Yang; Yan-Jun Liu; Li-Jian Ding; Fan Tao; Ming-Hui Zhu; Zhen-Yuan Shi; Juan-Ming Wen; Meng-Yao Niu; Xiang Li; Zhan-Song Xu; Wan-Jia Qin; Chen-Jie Fei; Jiong Chen
Journal:  Front Pharmacol       Date:  2022-09-16       Impact factor: 5.988

10.  N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1.

Authors:  Chenliang Zhou; Zhichang Zhang; Xiaoshi Zhu; Guowei Qian; Yan Zhou; Yong Sun; Wenxi Yu; Jiahui Wang; Haiyang Lu; Feng Lin; Zan Shen; Shuier Zheng
Journal:  EBioMedicine       Date:  2020-08-24       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.